Geriatric assessment in clinical practice for patients with stage IV non-small-cell lung cancer: The Grup de Investigacio I Divulgacio Oncologica experience


Por: Gironés R, Aparisi F, García-Sánchez J, Sánchez-Hernández A, Garcia Pinon, F and Juan-Vidal Ó

Publicada: 1 nov 2018
Categoría: Oncology

Resumen:
Therapeutic decision-making for older patients with stage IV non-small-cell lung cancer (NSCLC) with no identifiable activating mutation is complex. In this prospective study, we evaluated the usefulness of geriatric assessment (GA) in identifying frail patients. Stage IV NSCLC patients >= 70 years of age were evaluated with GA and classified according to this evaluation into three different groups: fit, vulnerable and frail. Classifications based on GA, treatment decision, toxicity and overall survival were analysed. In total, 93 patients were included. Median age was 76 (70-92) years and 90% were men. Most patients had performance status (PS) 0 or 1 (82%), unrelated to their GA (p = 0.006). GA groups were associated with overall survival (p = 0.000), treatment decision (p = 0.0001), and toxicity (p = 0.0001). Chemotherapy was delivered to 100% of fit patients, to 48% of vulnerable patients, and to only 8% of frail patients (p = 0.000). Toxicity was higher in vulnerable patients than in fit individuals (p = 0.000). Multivariable analysis showed PS (p = 0.001), active treatment (p 0.001) and GA group (p = 0.001) to be prognostic factors related to survival. Our results suggest that GA identified patients with poor natural prognosis.

Filiaciones:
:
 Hosp Lluis Alcanyis, Med Oncol Unit, Xativa, Spain

 Hospital Lluis Alcanyís, Medical Oncology Unit, Xátiva, Spain

:
 Hosp Gen Valencia, Valencia, Spain

 Hospital General de Valencia, Valencia, Spain

:
 Hosp Arnau Vilanova, Med Oncol Unit, Valencia, Spain

 Hospital Arnau de Vilanova, Medical Oncology Unit, Valencia, Spain

Sánchez-Hernández A:
 Consorcio Hosp Prov Castellon, Med Oncol Serv, Castellon de La Plana, Spain

 Consorcio Hospitalario Provincial de Castellón, Medical Oncology Service, Castellón, Spain

Garcia Pinon, F:
 GIDO, Valencia, Spain

Juan-Vidal Ó:
 Hopsital Univ & Politecn La Fe, Valencia, Spain

 Hopsital Universitari i Politécnic La Fe, Valencia, Spain

Freelance Biostatistician Assigned to GIDO, Valencia, Spain
ISSN: 09615423





EUROPEAN JOURNAL OF CANCER CARE
Editorial
WILEY, 111 RIVER ST, HOBOKEN 07030-5774, NJ USA, Reino Unido
Tipo de documento: Article
Volumen: 27 Número: 6
Páginas:
WOS Id: 000451570300007
ID de PubMed: 30357951

MÉTRICAS